Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

about

An elevated serum alkaline phosphatase level in hepatic metastases of grade 1 and 2 gastrointestinal neuroendocrine tumors is unusual and of prognostic value.Molecular subtypes in cancers of the gastrointestinal tract.[Grading of neuroendocrine tumors].

P2860

Q33745867-BF6264BB-33DC-46F6-9FC9-F05CD4A21662 Q39235977-0E369DAE-AFDC-42BA-9EC8-B319DC1FCC2D Q53073082-9C3C2D6B-2BA9-4919-BF82-03726EF72B18

P2860

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

Item

http://www.wikidata.org/entity/Q40773502

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

@en

type

Item

label

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

@en

prefLabel

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

@en

P1476

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

@en

P2093

Lisa Hauck

http://www.w3.org/2001/XMLSchema#string

Michael Bitzer

http://www.w3.org/2001/XMLSchema#string

Nisar Malek

http://www.w3.org/2001/XMLSchema#string

Ruben R Plentz

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the mTOR signaling pathway in neuroendocrine tumors

The Ki-67 protein: from the known and the unknown

The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems

Neuroendocrine tumors of the gastro-entero-pancreatic system

Clinical characterization of pulmonary large cell neuroendocrine carcinoma and large cell carcinoma with neuroendocrine morphology.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

A new era for the systemic therapy of neuroendocrine tumors.

Chemotherapy for gastro-enteropancreatic endocrine tumours.

Prognostic factors in gastrointestinal endocrine tumors.

P304

55-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365521.2015.1064994

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26137871

http://www.w3.org/2001/XMLSchema#string

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

about

P2860

P2860

Subgroup analysis of patients with G2 gastroenteropancreatic neuroendocrine tumors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698